1. Impurity Analysis of Lamivudine According to USP Method (CDBS-453)
  2. Impurity Analysis of Voriconazole According to USP Method (CDBS-453)
  3. Analysis of Formoterol Fumarate Dihydrate According to Pharmacopeia Method (ODP-50 4D)
  4. LC/MS/MS Analysis of Salacia Extract (2) (VT-50 2D)
  5. LC/MS/MS Analysis of Salacia Extract (1) (VC-50 2D)
  6. LC/MS/MS Analysis of Citicoline (VT-50 2D)
  7. LC/MS Analysis of Streptomycins (VC-50 2D)
  8. Comparison of Analysis of Glucosamine Hydrochloride between Polymer-based Amino Columns and Silica-based Amino Columns
  9. Assay of Polyethylene Glycol 3350 for Oral Solution According to USP Method (SB-802.5 HQ)
  10. Measurement of Apparent Weight-Average Molecular Weight and Polydispersity of Polyethylene Glycol 3350 According to USP Method (SB-803 HQ)
  11. LC/MS/MS Analysis of Salacia Extract (1) (VC-50 2D)
  12. LC/MS/MS Analysis of Ribavirin (VC-50 2D)
  13. Analysis of High Molecular Impurities in Insulin Aspart According to Pharmacopoeia Method (KW-802.5)
  14. Dissolution Test of Ribavirin Capsules according to JP Method (Y-521)
  15. LC/MS Analysis of Aminoglycoside Antibiotics (VC-50 2D)
  16. Drugs (ODP-50 4D)
  17. Soyasaponin in Soy Bean (DS-613)
  18. LC/MS/MS Analysis of Oral Anti-diabetes Drugs (VC-50 2D)
  19. Analysis of Voglibose According to JP Method (NH2P-50 4E)
  20. Analysis of Catechin (C18P 4D)
  21. Bibliographic Information for Analysis of Conjugate Vaccine
  22. Separation of Gingerol and Shogaol (C18M 4D)
  23. Analysis of Purified Sodium Hyaluronate Ophthalmic Solution According to JP Method (SB-802.5 HQ)
  24. Analysis of Miglitol According to JP Method (NH2P-50 4E)
  25. Analysis of Insulin According to USP Method (KW-802.5)
  26. Analysis of Insulin Glargine According to JP Method (KW-802.5)
  27. Analysis of Insulin Human According to JP Method (KW-802.5)
  28. Analysis of Zanamivir According to USP Method (NH2P-50 4E)
  29. Analysis of Glucosamine According to USP Method (5NH 4D)
  30. Analysis of Allantoin (JJ-50 4D)
  31. Analysis of Azithromycin According to USP Method (ODP-50 4E)
  32. LC/MS Analysis of Metformin (NH2P-40 2D)
  33. Simultaneous Analysis of Multi Symptom Cold Formula (ODP2 HP)
  34. Simultaneous Analysis of Multi Symptom Cold Formula in Serum (ODP2 HP)
  35. LC/MS Analysis of Statins (ODP2 HP-2B)
  36. LC/MS Analysis of Basic Drugs (ODP40-2D)
  37. Basic sample (Procainamide, N-Acetylprocainamide) (Shodex C18-4D)
  38. Coenzyme Q10
  39. Anti-diabetes drugs (NH2P-50 4E)
  40. Anticonvulsant (Shodex C18-4D)
  41. Paeoniflorin (Shodex C18-4D)
  42. Anti-inflammatory agent (Shodex C18-4D)
  43. Basic sample (Scopolamine, Atropine) (Shodex C18-4D)
  44. Berberine (Shodex C18-4D)
  45. Cold remedy (1) (Shodex C18-4D)
  46. Cold remedy (2) (Shodex C18-4D)
  47. Glycyrrhizin (Shodex C18-4D)
  48. Macrolide antibiotics and derivatives
  49. Ribavirin (KS-801)
  50. Ginsenoside (Ginseng Saponin)
  51. Short Amines (ODP2 HP-4D)
  52. Analysis of Short Amines without Using Ion Pair Reagent
  53. Procaine and Procaineamide (ODP-50 4D)
  54. Methylxanthine (1) (DS-613)
  55. Methylxanthine (2)
  56. Local Anesthetics (1) (ODP-50 4D)
  57. Local Anesthetics (2) (DE-413)
  58. Cinchona Alkaloids
  59. Antibiotics (1) (ODP-50 4D)
  60. Antibiotics (2) (DE-413)
  61. Sulfanilamides (DE-413)
  62. Barbiturates (ODP-50 4D)
  63. Effect of pH of Eluent on Sensitivity of Barbital
  64. Berberine in Japanese Goldthread
  65. Glycyrrhizin in Licorice
  66. Saikosaponins (ODP-50 6D)
  67. Soysaponin in Soy Beans (DS-613)
  68. Curative medicine to eradicate H.Pyrori
  69. Enalapril Maleate (DS-413)
  70. Tetracycline Derivative Antibiotics
  71. Basic Drugs : Under Neutral Condition
  72. Basic Drugs : Effect of Eluent pH
  73. Basic Drugs : Effect of Ion Concentration
  74. Antifebriles (1) (DS-613)
  75. Antifebriles (2) (DM-614)
  76. Antipyretic Analgesics (ODP-50 4D)
  77. Diuretics (1) (ODP-50 4D)
  78. Diuretics (2) (DE-613)
  79. Anti Cancer Drugs (ODP-50 4D)
  80. Drugs
  81. Anti Inflammatory Drugs (1) (ODP-50 4E)
  82. Anti Inflammatory Drugs (2) (ODP-50 4E)
  83. Scopolamine and Atropine (ODP-50 4D)
  84. Tetracaine (ODP-50 4D)
  85. Effect of pH of Eluent on Elution Volume and Plate Number
  86. Procainamides (1) (DE-613)
  87. Procainamides (2) (DE-413)